All Type of News
KFDA to re-categorize drugs
The Korea Food and Drug Administration (KFDA) will re-categorize 507 medicines from March as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug use.
The authoritie...
Dong-A PharmTech announces start of Phase II trials for Udenafil in Mexico
Dong-A PharmTech Co. announced Monday that it will carry out Phase II clinical trials for Zydena (udenafil), a new long acting drug for treatment of erectile dysfunction (ED), in Mexico.
In its regulatory filing, t...
More steps to cut down kickbacks to doctors
A civic group said Monday that despite efforts to root out the practice, drug firms are still deeply involved in paying kickbacks to doctors to use their products, citing the recent case that seven former and incumben...
Multinational drug firms challenge new guideline
A dispute has arisen over the planned introduction of a Fair Trade Commission (FTC)-drafted guideline for fair business practice in domestic pharmaceutical sector.
The Korean-based Pharmaceutical Industry Associati...
Drug wholesalers need protection from large drug makers
Three large firms, such as CJ Pharm, Daewoong Pharm and Hanmi Pharm, are now rushing to expand their online drug business to boost the revenues hit by comprehensive price cuts of drugs by the government last April.
...
Dong-A boosting R&D spending
Top local drug maker Dong-A Pharmaceutical plans to spend more on research and development (R&D) projects in a bid to accelerate development of new original drugs and increase exports.
The company announced Friday ...
KMA to step up primary care
The Korean Medical Association (KMA) has recently unveiled its plan to strengthen the footing of the nation’s primary care, while seeking to prevent hospitals and clinics from falsifying medical records to overcharge ...
KFDA discloses real name of kickbacks provider
The Korea Food and Drug Administration has recently banned Jesambiozam Co. from selling trochisan (dental product) for 30 days for offering kickbacks to doctors and pharmacists, revealing that Shinpoong Pharm provided...
Illegal rebate case overshadows pharmaceutical industry
Seven former and incumbent executives of Dong-A Pharmaceutical were indicted Thursday for providing 4.8 billion won in kickbacks to hospitals and clinics, which has casted a dark shadow over domestic and foreign busin...
Hanmi Pharm is open to dialogue with wholesalers over online drug shopping mall
Hanmi Pharm said that doors are always open for dialogue and cooperation with local wholesalers over its HMP mall, an online drug shopping mall.
In a statement delivered to the Korea Pharmaceutical Wholesaler Assoc...
